1|Page
NR 546 Midterm Exam Advanced Pharmacology
Psychopharmacology PMHNP 2026/2027 Actual Exam
Questions with Verified Answers and Detailed
Rationales NGN Grade A+
1. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
Correct Answer: Structural factors
Rationale: The patient's denial of illness (lack of insight) is a structural factor related to
the disorder itself.
,2|Page
2. Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
Correct Answer: Medication education
Rationale: Explaining medication details is part of medication education to promote
adherence.
3. A patient recovering from a stroke has trouble with speech comprehension and
works with a speech therapist twice a week. Which part of the patient's brain has
been affected by the stroke?
A. The Broca's area
B. The Basal ganglia
C. The Limbic system
D. The Wernicke's area
,3|Page
Correct Answer: The Wernicke's area
Rationale: Wernicke's area is responsible for language comprehension; damage causes
receptive aphasia.
4. Which of the following poses a potential ethical concern when prescribing
psychiatric medications?
A. The patient is homeless and uninsured
B. The patient poses a risk to themself as they state they are experiencing very scary
auditory and visual hallucinations
C. The patient's family voices a stigma against psychiatric medications
D. The patient states they worry about the potential side effects of the medication
Correct Answer: The patient poses a risk to themself as they state they are
experiencing very scary auditory and visual hallucinations
Rationale: Patient safety and risk of harm to self or others is an ethical concern
requiring intervention.
5. What is the name of the lobe that controls visual processing?
A. Gyrus
B. Frontal Lobe
, 4|Page
C. Occipital Lobe
D. Parietal Lobe
Correct Answer: Occipital Lobe
Rationale: The occipital lobe is responsible for visual processing.
6. The cerebellum, cerebrum, brain stem, and butterfly-shaped portion of the central
spinal cord are comprised of _______________ which contains neural cell bodies, axon
terminals, dendrites, and all nerve synapses.
A. Frontal lobe
B. White matter
C. Grey matter
D. Corpus callosum
Correct Answer: Grey matter
Rationale: Grey matter contains neural cell bodies, dendrites, and synapses.
7. What is the function of the central sulcus?
A. Separates the temporal from the occipital lobe
B. Separates the frontal from the parietal lobe
NR 546 Midterm Exam Advanced Pharmacology
Psychopharmacology PMHNP 2026/2027 Actual Exam
Questions with Verified Answers and Detailed
Rationales NGN Grade A+
1. A 22-year-old patient recently diagnosed with bipolar disorder states, "I'm not
crazy," and is refusing to take his prescribed medication. Which type of factor is
contributing to this patient's nonadherence?
A. Client factors
B. Clinician factors
C. Structural factors
D. Environmental factors
Correct Answer: Structural factors
Rationale: The patient's denial of illness (lack of insight) is a structural factor related to
the disorder itself.
,2|Page
2. Using Dell'Osso et al.'s sequential framework of priorities to promote medication
adherence, determine which step is being defined: The PMHNP explains the
mechanism of action, anticipated time to experience effects, side effects, and lifestyle
instructions to a patient after prescribing Wellbutrin.
A. Diagnosis
B. Medication education
C. Monitoring plan
D. Adherence reinforcement
Correct Answer: Medication education
Rationale: Explaining medication details is part of medication education to promote
adherence.
3. A patient recovering from a stroke has trouble with speech comprehension and
works with a speech therapist twice a week. Which part of the patient's brain has
been affected by the stroke?
A. The Broca's area
B. The Basal ganglia
C. The Limbic system
D. The Wernicke's area
,3|Page
Correct Answer: The Wernicke's area
Rationale: Wernicke's area is responsible for language comprehension; damage causes
receptive aphasia.
4. Which of the following poses a potential ethical concern when prescribing
psychiatric medications?
A. The patient is homeless and uninsured
B. The patient poses a risk to themself as they state they are experiencing very scary
auditory and visual hallucinations
C. The patient's family voices a stigma against psychiatric medications
D. The patient states they worry about the potential side effects of the medication
Correct Answer: The patient poses a risk to themself as they state they are
experiencing very scary auditory and visual hallucinations
Rationale: Patient safety and risk of harm to self or others is an ethical concern
requiring intervention.
5. What is the name of the lobe that controls visual processing?
A. Gyrus
B. Frontal Lobe
, 4|Page
C. Occipital Lobe
D. Parietal Lobe
Correct Answer: Occipital Lobe
Rationale: The occipital lobe is responsible for visual processing.
6. The cerebellum, cerebrum, brain stem, and butterfly-shaped portion of the central
spinal cord are comprised of _______________ which contains neural cell bodies, axon
terminals, dendrites, and all nerve synapses.
A. Frontal lobe
B. White matter
C. Grey matter
D. Corpus callosum
Correct Answer: Grey matter
Rationale: Grey matter contains neural cell bodies, dendrites, and synapses.
7. What is the function of the central sulcus?
A. Separates the temporal from the occipital lobe
B. Separates the frontal from the parietal lobe
